“…In the remaining 6 guidelines (ACCF1 [15], AHA2 [8], National Cholesterol Education Program [NCEP] [16,17], CAR [18], CCS2 [19], and ACCF2 [20]), testing was only advocated for patients with an a priori elevated risk level based on absolute CAD risk or multiple risk factors. Generally, risk was determined by Framingham risk equations for estimation of a 10-year risk for coronary events (fatal and nonfatal) using the categories Ͻ10%, 10% to 20%, and Ͼ20% for, respectively, low, intermediate, and high risk.…”